|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Aerovate Therapeutics, Inc. (AVTE) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
27,670,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Aerovate Therapeutics is a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Co.'s initial focus is on improving AV-101, its dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. AV-101, delivered using a dry powder inhaler, is designed to provide lung concentrations at or above those observed with the oral dose while limiting systemic levels of the drug.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
928,110 |
928,110 |
928,110 |
Total Buy Value |
$0 |
$1,549,944 |
$1,549,944 |
$1,549,944 |
Total People Bought |
0 |
1 |
1 |
1 |
Total Buy Transactions |
0 |
1 |
1 |
1 |
Total Shares Sold |
0 |
150,361 |
329,022 |
735,489 |
Total Sell Value |
$0 |
$3,912,078 |
$7,720,188 |
$15,926,618 |
Total People Sold |
0 |
6 |
7 |
7 |
Total Sell Transactions |
0 |
18 |
43 |
103 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gillies Hunter |
CHIEF MEDICAL OFFICER |
|
2023-05-17 |
4 |
AS |
$19.59 |
$21,356 |
D/D |
(1,090) |
3,251 |
|
- |
|
Gillies Hunter |
CHIEF MEDICAL OFFICER |
|
2023-05-17 |
4 |
OE |
$1.74 |
$1,897 |
D/D |
1,090 |
4,341 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2023-05-08 |
4 |
AS |
$21.62 |
$224,160 |
D/D |
(10,284) |
1,291 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2023-05-08 |
4 |
OE |
$1.74 |
$21,043 |
D/D |
10,284 |
11,575 |
|
- |
|
Niven Ralph |
CHIEF SCIENTIFIC OFFICER |
|
2023-05-05 |
4 |
AS |
$20.79 |
$46,957 |
D/D |
(2,250) |
1,609 |
|
- |
|
Niven Ralph |
CHIEF SCIENTIFIC OFFICER |
|
2023-05-05 |
4 |
OE |
$1.74 |
$4,555 |
D/D |
2,250 |
3,859 |
|
- |
|
Verwijs Marinus |
SENIOR VICE PRESIDENT, CMC |
|
2023-05-03 |
4 |
S |
$20.79 |
$15,779 |
D/D |
(759) |
0 |
|
- |
|
Noyes Timothy P |
CHIEF EXECUTIVE OFFICER |
|
2023-05-02 |
4 |
AS |
$21.15 |
$14,657 |
D/D |
(693) |
0 |
|
- |
|
Noyes Timothy P |
CHIEF EXECUTIVE OFFICER |
|
2023-05-01 |
4 |
AS |
$20.61 |
$309,089 |
D/D |
(15,000) |
693 |
|
- |
|
Noyes Timothy P |
CHIEF EXECUTIVE OFFICER |
|
2023-05-01 |
4 |
OE |
$2.14 |
$32,100 |
D/D |
15,000 |
15,693 |
|
- |
|
Gillies Hunter |
CHIEF MEDICAL OFFICER |
|
2023-04-21 |
4 |
AS |
$19.50 |
$78,000 |
D/D |
(4,000) |
1,960 |
|
- |
|
Gillies Hunter |
CHIEF MEDICAL OFFICER |
|
2023-04-21 |
4 |
OE |
$1.74 |
$6,960 |
D/D |
4,000 |
5,960 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2023-04-06 |
4 |
AS |
$18.17 |
$186,829 |
D/D |
(10,283) |
0 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2023-04-06 |
4 |
OE |
$1.74 |
$21,041 |
D/D |
10,283 |
10,283 |
|
- |
|
Niven Ralph |
CHIEF SCIENTIFIC OFFICER |
|
2023-04-05 |
4 |
AS |
$17.91 |
$40,942 |
D/D |
(2,250) |
1,609 |
|
- |
|
Niven Ralph |
CHIEF SCIENTIFIC OFFICER |
|
2023-04-05 |
4 |
OE |
$1.74 |
$4,555 |
D/D |
2,250 |
3,859 |
|
- |
|
Noyes Timothy P |
CHIEF EXECUTIVE OFFICER |
|
2023-04-03 |
4 |
AS |
$19.16 |
$290,916 |
D/D |
(15,000) |
0 |
|
- |
|
Noyes Timothy P |
CHIEF EXECUTIVE OFFICER |
|
2023-04-03 |
4 |
OE |
$2.14 |
$32,100 |
D/D |
15,000 |
15,000 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2023-03-06 |
4 |
AS |
$23.71 |
$243,954 |
D/D |
(10,282) |
0 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2023-03-06 |
4 |
OE |
$1.74 |
$21,039 |
D/D |
10,282 |
10,282 |
|
- |
|
Niven Ralph |
CHIEF SCIENTIFIC OFFICER |
|
2023-03-06 |
4 |
AS |
$23.73 |
$53,440 |
D/D |
(2,250) |
1,609 |
|
- |
|
Niven Ralph |
CHIEF SCIENTIFIC OFFICER |
|
2023-03-06 |
4 |
OE |
$1.74 |
$4,555 |
D/D |
2,250 |
3,859 |
|
- |
|
Noyes Timothy P |
CHIEF EXECUTIVE OFFICER |
|
2023-03-01 |
4 |
AS |
$22.71 |
$357,196 |
D/D |
(15,000) |
0 |
|
- |
|
Noyes Timothy P |
CHIEF EXECUTIVE OFFICER |
|
2023-03-01 |
4 |
OE |
$2.14 |
$32,100 |
D/D |
15,000 |
15,000 |
|
- |
|
Dake Benjamin T |
SEE REMARKS |
|
2023-02-06 |
4 |
AS |
$24.52 |
$252,881 |
D/D |
(10,284) |
0 |
|
- |
|
232 Records found
|
|
Page 5 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|